Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yoon Se Lee, Daniel E. Johnson & Jennifer R. Grandis. (2018) An update: emerging drugs to treat squamous cell carcinomas of the head and neck. Expert Opinion on Emerging Drugs 23:4, pages 283-299.
Read now
Read now
Cristiana Lo Nigro, Nerina Denaro, Anna Merlotti & Marco Merlano. (2017) Head and neck cancer: improving outcomes with a multidisciplinary approach. Cancer Management and Research 9, pages 363-371.
Read now
Read now
Olgun Elicin & Mahmut Ozsahin. (2017) The latest prospects of investigational drugs for head and neck cancer. Expert Opinion on Investigational Drugs 26:3, pages 265-268.
Read now
Read now
Stefan Hartmann & Jennifer R. Grandis. (2016) Treatment of head and neck cancer in the elderly. Expert Opinion on Pharmacotherapy 17:14, pages 1903-1921.
Read now
Read now
Articles from other publishers (8)
Ya Chen, Yuan Jiang, Xinyu Huang, Lin Chen, Hao Yang, Jian Zhao & Beibei Liang. (2022) Cordycepin Inhibits the Growth of Hepatocellular Carcinoma by Regulating the Pathway of Aerobic Glycolysis. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-14.
Crossref
Crossref
Valerie Cristina, Ruth Gabriela Herrera-Gómez, Petr Szturz, Vittoria Espeli & Marco Siano. (2019) Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences 20:21, pages 5399.
Crossref
Crossref
Paolo Bossi, Salvatore Alfieri, Primoz Strojan, Robert P. Takes, Fernando López, Antti Mäkitie, Nabil F. Saba, Juan Pablo Rodrigo, Carol Bradford, Carlos Suarez, Mark Zafereo, Arlene A. Forastiere, Jan B. Vermorken, Miquel Quer, Alvaro Sanabria, Ricard Simo, Remco de Bree, Alessandra Rinaldo & Alfio Ferlito. (2019) Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature. Critical Reviews in Oncology/Hematology 137, pages 84-91.
Crossref
Crossref
Julia Hess, Kristian Unger, Cornelius Maihoefer, Lars Schüttrumpf, Ludmila Wintergerst, Theresa Heider, Peter Weber, Sebastian Marschner, Herbert Braselmann, Daniel Samaga, Sebastian Kuger, Ulrike Pflugradt, Philipp Baumeister, Axel Walch, Christine Woischke, Thomas Kirchner, Martin Werner, Kristin Werner, Michael Baumann, Volker Budach, Stephanie E. Combs, Jürgen Debus, Anca-Ligia Grosu, Mechthild Krause, Annett Linge, Claus Rödel, Martin Stuschke, Daniel Zips, Horst Zitzelsberger, Ute Ganswindt, Michael Henke & Claus Belka. (2019) A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection. Clinical Cancer Research 25:5, pages 1505-1516.
Crossref
Crossref
Nene N. Kalu, Tuhina Mazumdar, Shaohua Peng, Pan Tong, Li Shen, Jing Wang, Upasana Banerjee, Jeffrey N. Myers, Curtis R. Pickering, David Brunell, Clifford C. Stephan & Faye M. Johnson. (2018) Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants. Cancer Letters 431, pages 64-72.
Crossref
Crossref
Salvatore Alfieri, Stefano Cavalieri & Lisa Licitra. (2018) Immunotherapy for recurrent/metastatic head and neck cancer. Current Opinion in Otolaryngology & Head & Neck Surgery 26:2, pages 152-156.
Crossref
Crossref
Adrian D. Schubert, Fernando T. Zamuner, Nyall R. LondonJrJr, Alex Zhavoronkov, Ranee Mehra, Mohammad O. Hoque, Atul Bedi, Rajani Ravi, Elana J. Fertig, David Sidransky, Daria A. Gaykalova & Evgeny Izumchenko. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
229
248
.
Mary Glorieux, Rüveyda Dok & Sandra Nuyts. (2017) Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers. Oncotarget 8:46, pages 81662-81678.
Crossref
Crossref